Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01285050 · ClinicalTrials.gov registry record · Phase 4
Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01285050: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT01285050 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01285050, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The chief purpose of this research is to evaluate interferon alpha sensitivity and cell type specific levels of interferon receptor and interferon stimulated genes and proteins in HIV/ HCV (hepatitis C virus) coinfected persons before and after administration of HIV medications (antiretroviral therapy).
Primary Outcome
HCV RNA determined by reverse transcription polymerase chain reaction and measured as log IU/ml 48 hours after a single dose of peginterferon alfa 2b 1.5 μg/kg.
Interventions
- DRUG Emtricitabine and tenofovir disoproxil fumarate
- DRUG raltegravir
- DRUG Antiretroviral therapy (ART)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-04 |
| Phase | Phase 4 |
What the finished NCT01285050 record still lists
NCT01285050 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Emtricitabine and tenofovir disoproxil fumarate is the first listed.
NCT01285050 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01285050 about?
NCT01285050 is a clinical study titled "Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds". The chief purpose of this research is to evaluate interferon alpha sensitivity and cell type specific levels of interferon receptor and interferon stimulated genes and proteins in HIV/ HCV (hepatitis C virus) coinfected persons before and after administration of HIV medications (antiretroviral thera...
What is the current status of trial NCT01285050?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2011-01. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01285050?
The interventions under investigation include: Emtricitabine and tenofovir disoproxil fumarate (DRUG), raltegravir (DRUG), Antiretroviral therapy (ART) (DRUG).
Who is sponsoring clinical trial NCT01285050?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01285050's enrollment target sits among peer trials
20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia